Aldeyra Therapeutics, Inc.
ALDX· Nasdaq
ALDXAldeyra Therapeutics, Inc.
Filed Mar 8, 2019 · 10-K · 67 days after period end · 0001564590-19-006997
derived · Computed from the longer spans the company filed.
| Metric | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$10.63M | — | — | -$4.36M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aldeyra Therapeutics, Inc. · CIK 1341235 · Engraved from SEC EDGAR
ended Dec 31, 2018 · filed Mar 8, 2019 · 67 d after period end
